These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19419786)

  • 41. Hyperhomocysteinemia and thrombosis.
    Guba SC; Fonseca V; Fink LM
    Semin Thromb Hemost; 1999; 25(3):291-309. PubMed ID: 10443960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of serum paraoxon hydrolyzing activity in a large Spanish population using a routine automized method in clinical laboratory.
    Carrera V; Llopis I; Sastre J; Sogorb MA; Vilanova E
    J Anal Toxicol; 2003; 27(5):290-3. PubMed ID: 12908942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients.
    Angayarkanni N; Barathi S; Seethalakshmi T; Punitham R; Sivaramakrishna R; Suganeswari G; Tarun S
    Eye (Lond); 2008 Jul; 22(7):969-74. PubMed ID: 18084236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for telomerase activation in VSMCs exposed to hyperglycemic and hyperhomocysteinemic conditions.
    Jacob T; Hingorani A; Ascher E
    Angiology; 2009; 60(5):562-8. PubMed ID: 19398425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
    Jornayvaz FR; Brulhart-Meynet MC; James RW
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative hydrolysis of O-hexyl O-2,5-dichlorophenyl phosphoramidate and paraoxon in different tissues of vertebrates.
    Monroy-Noyola A; Rojas P; Vilanova E; Sogorb MA
    Arch Toxicol; 2007 Oct; 81(10):689-95. PubMed ID: 17396245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
    Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
    Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cadmium administration in hyperhomocysteinemic mice due to cystathionine beta synthase deficiency.
    Ramambason C; Moroy G; Daubigney F; Paul JL; Janel N
    Exp Toxicol Pathol; 2016 Jun; 68(6):365-70. PubMed ID: 27165444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzyme visualization with partially dehydrated agarose substrate layers: detection of paraoxonase after thin-layer isoelectric focusing in agarose.
    Haas A; Geldmacher-von Mallinckrodt M
    Electrophoresis; 1990 Aug; 11(8):621-6. PubMed ID: 1963139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
    McElveen J; Mackness MI; Colley CM; Peard T; Warner S; Walker CH
    Clin Chem; 1986 Apr; 32(4):671-3. PubMed ID: 3006944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Docking and molecular dynamics simulation studies on glycation-induced conformational changes of human paraoxonase 1.
    Saleem A; Azam SS; Zarina S
    Eur Biophys J; 2012 Feb; 41(2):241-8. PubMed ID: 22193970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of serum paraoxon hydrolyzing activities in a Canadian population.
    Carro-Ciampi G; Kadar D; Kalow W
    Can J Physiol Pharmacol; 1981 Aug; 59(8):904-7. PubMed ID: 7296389
    [No Abstract]   [Full Text] [Related]  

  • 56. Investigation of methionine metabolism in peripheral blood mononuclear cells of Irish hyperhomocysteinemic subjects.
    Betts V; Collins PB; Meleady R; Graham I
    Biochem Soc Trans; 1998 Feb; 26(1):S10. PubMed ID: 10909768
    [No Abstract]   [Full Text] [Related]  

  • 57. [Analytical characteristics of the preparation of phosphacol (p-nitrophenyldiethylphosphate)].
    RUZHENTSEVA AK; LONDAREVA GP
    Med Prom SSSR; 1952; 2():35-7. PubMed ID: 14929017
    [No Abstract]   [Full Text] [Related]  

  • 58. Homocysteine levels in Indian women with Polycystic Ovary Syndrome.
    Agilli M; Aydin FN; Cayci T; Kurt YG
    J Clin Diagn Res; 2014 Oct; 8(10):CL01. PubMed ID: 25478338
    [No Abstract]   [Full Text] [Related]  

  • 59. The relationship between homocysteine and uric acid levels in gouty patients.
    Agilli M; Aydin FN; Cayci T; Kurt YG
    J Korean Med Sci; 2014 Sep; 29(9):1328. PubMed ID: 25246756
    [No Abstract]   [Full Text] [Related]  

  • 60. Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia.
    Türkeli H; Caycı T; Akgül EÖ; Macit E; Yaman H; Aydın I; Demirin H; Alacam H; Ozkan E; Cakır E; Deren O; Erbil MK; Kunak ZI; Burat K; Akman S
    Int J Cardiol; 2010 Nov; 145(1):42-3. PubMed ID: 19419786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.